GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / US Biomax / Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed / Product Detail : BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed
#BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed
Product name : Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed
Catalog number : BC19021
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
About this Product :Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed.
Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed storing antibdies for longer storage periods of the Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed we recommend - 21C or lower and for short periods lees than 1 month we suggest +5C fridge temperatures.
More Details about
|Microarray Panel:||Prostatic carcinoma, matched adjacent normal tissue and unmatched normal tissue microarray, containing 16 cases of adenocarcinoma, 8 adjacent normal tissue and 4 normal prostate tissue, triplicate cores per case of carcinoma, duplicate cores per case of adjacent normal and normal tissue|
|Layout:||9 cols × 8 rows|
|Core Diameter:||1.5 mm|
|Quality Control:||Anti-Actin confirmed|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases_72 cores; ihc Anti-Actin confirmed
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP2263: Prostate Cancer
WP1019: FAS pathway and Stress induction of HSP regulation
WP1062: Regulation of Actin Cytoskeleton
WP1138: FAS pathway and Stress induction of HSP regulation
WP1178: Regulation of Actin Cytoskeleton
WP1380: Regulation of Actin Cytoskeleton
WP1589: Folate-Alcohol and Cancer Pathway
WP1963: The effect of Glucocorticoids on target gene expression
WP1968: genetic alternations of lung cancer
WP1971: Integrated Cancer pathway
WP1984: Integrated Breast Cancer Pathway
WP2107: pathways in human cancer
WP2256: Integrated Pancreatic Cancer Pathway
WP2272: Pathogenic Escherichia coli infection
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2292: Chemokine signaling pathway
WP2335: sGC Cancer
WP2361: Gastric cancer network 1
WP2363: Gastric cancer network 2
WP2367: Private Pancreatic Cancer
WP2377: Integrated Pancreatic Cancer Pathway
WP2411: Cancer prevention Q
WP2429: Cancer prevention Q
WP314: FAS pathway and Stress induction of HSP regulation
WP351: Regulation of Actin Cytoskeleton
Related Genes :
[AR DHTR NR3C4] Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
[FOLH1 FOLH NAALAD1 PSM PSMA GIG27] Glutamate carboxypeptidase 2 (EC 188.8.131.52) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[CLU APOJ CLI KUB1 AAG4] Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Testosterone-repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)]
[KLK3 APS] Prostate-specific antigen (PSA) (EC 184.108.40.206) (Gamma-seminoprotein) (Seminin) (Kallikrein-3) (P-30 antigen) (Semenogelase)
[TAOK2 KIAA0881 MAP3K17 PSK PSK1 UNQ2971/PRO7431] Serine/threonine-protein kinase TAO2 (EC 220.127.116.11) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2)
[PTEN MMAC1 TEP1] Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 18.104.22.168) (EC 22.214.171.124) (EC 126.96.36.199) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)
[Shh Hhg1] Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product (Sonic hedgehog protein 19 kDa product); Sonic hedgehog protein C-product (Sonic hedgehog protein 27 kDa product)]
[STEAP2 PCANAP1 STAMP1 UNQ6507/PRO23203] Metalloreductase STEAP2 (EC 1.16.1.-) (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer) (PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1)
[CTNNB1 CTNNB OK/SW-cl.35 PRO2286] Catenin beta-1 (Beta-catenin)
[ELAC2 HPC2] Zinc phosphodiesterase ELAC protein 2 (EC 188.8.131.52) (ElaC homolog protein 2) (Heredity prostate cancer protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2)
[CHEK2 CDS1 CHK2 RAD53] Serine/threonine-protein kinase Chk2 (EC 184.108.40.206) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)
[ALKBH3 ABH3 DEPC1] Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 3) (hABH3) (DEPC-1) (Prostate cancer antigen 1)
[TAOK1 KIAA1361 MAP3K16 MARKK] Serine/threonine-protein kinase TAO1 (EC 220.127.116.11) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1)
[ANO7 NGEP PCANAP5 TMEM16G] Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G)
[Clu] Clusterin (Dimeric acid glycoprotein) (DAG) (Sulfated glycoprotein 2) (SGP-2) (Testosterone repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain; Clusterin alpha chain]
[Pawr Par4] PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein) (Par-4) (Transcriptional repressor Par-4-like protein PAWR)
[FGFR2 BEK KGFR KSAM] Fibroblast growth factor receptor 2 (FGFR-2) (EC 18.104.22.168) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332)
[DAB2IP AF9Q34 AIP1 KIAA1743] Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein)
[PAWR PAR4] PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein) (Par-4)
[MSMB PRSP] Beta-microseminoprotein (Immunoglobulin-binding factor) (IGBF) (PN44) (Prostate secreted seminal plasma protein) (Prostate secretory protein of 94 amino acids) (PSP-94) (PSP94) (Seminal plasma beta-inhibin)
[STEAP3 TSAP6] Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6) (hTSAP6) (pHyde) (hpHyde)
[PMEPA1 STAG1 TMEPAI] Protein TMEPAI (Prostate transmembrane protein androgen induced 1) (Solid tumor-associated 1 protein) (Transmembrane prostate androgen-induced protein)
[RDH11 ARSDR1 PSDR1 SDR7C1 CGI-82] Retinol dehydrogenase 11 (EC 22.214.171.1240) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1)
[Notch1 Motch] Neurogenic locus notch homolog protein 1 (Notch 1) (Motch A) (mT14) (p300) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)]
[SHH] Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product; Sonic hedgehog protein C-product]
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53)
[PDS5B APRIN AS3 KIAA0979] Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3)
[Ctnnb1 Catnb] Catenin beta-1 (Beta-catenin)
[SPDEF PDEF PSE] SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor) (Prostate-specific Ets) (Prostate-derived Ets factor)
 Bladder rupture secondary to emphysematous bladder: A diabetic patient report.
 Spatial Localization and Quantitation of Androgens in Mouse Testis by Mass Spectrometry Imaging.
 Caloric Restriction Augments the Molecular Effects of Radiation in Both Hormone-Sensitive and Hormone-Insensitive Prostate Cancers by Decreasing Inflammation.
 The Biological Role and Clinical Significance of Long Noncoding RNA Urothelial Carcinoma Associated 1 (UCA1) in Prostate Cancer (PCa).
 Phase 1/2 Study of Urethral and Rectal Sparing Following Extreme Hypofractionated (5x9 Gy) Stereotactic Body Radiation Therapy in Prostate Cancer.
 Predictors of Multidomain Decline in Health-Related Quality of Life After Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer.
 Five-Year Outcomes From a Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer.
 Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost For Localized High-Risk Prostate Cancer: Five-Year Results of a Prospective Trial.
 Long-Term Outcomes of a Phase 2 Trial of Moderate Hypofractionated Image Guided Intensity Modulated Radiation Therapy (IG-IMRT) for Localized Prostate Cancer.
 Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer.
Enter catalog number :